Induction of genomic instability by HPV E6 and E7

HPV E6 和 E7 诱导基因组不稳定

基本信息

  • 批准号:
    7684264
  • 负责人:
  • 金额:
    $ 30.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-08 至 2013-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Human papillomavirus (HPV) infection is necessary but not sufficient for the development of cervical cancer. Genomic instability caused by HPV may enable cells to accumulate additional genetic abnormalities necessary for carcinogenesis and has been implicated in a causal role in carcinogenesis. Expression of the HPV E6 and E7 oncogenes in primary human keratinocytes (PHKs) leads to polyploidy, which is enhanced by spindle disruption and DNA damage. Previously, it was hypothesized that E6 and E7 induce polyploidy by abrogating the mitotic spindle checkpoint and that E6 degrades the tumor suppressor p53 to induce polyploidy. Our recent studies demonstrate that E6 and E7 do not have a significant effect on the spindle checkpoint. Instead, they abrogate the postmitotic checkpoint to induce polyploidy after microtubule disruption. Interestingly, E6 mutants defective in p53 degradation also induce polyploidy. Moreover, our studies suggest an important role for Cdk4 and Cdk1 in E6-induced polyploidy. In addition, E7 induces polyploidy in response to DNA damage through re-replication, a process of successive rounds of DNA replication without an intervening mitosis. Furthermore, we find that the DNA replication initiation factor Cdt1, whose uncontrolled expression induces re-replication in human cancer cells, is post-translationally modified during E7-induced re-replication. We hypothesize that activation of cdk4 and cdk1 plays an important role in p53-independent induction of polyploidy by E6, modification of Cdt1 is required for E7 to induce re-replication, and E6/E7-induced polyploidy will enhance the progression into aneuploidy and cancer. The specific aims of the proposal are designed to test these possibilities. These studies will shed light on mechanisms by which HPV induces genomic instability and hold promise for the identification of targets for drug development. PUBLIC HEALTH RELEVANCE: Infection with human papillomaviruses (HPV) induces warts and is strongly associated with the development of cervical cancer. Modulation of cell cycle checkpoints by the HPV oncogenes E6 and E7 contributes to HPV- induced genomic instability. These studies will shed light on mechanisms by which HPV induces cancer and hold promise for the identification of targets for drug development.
描述(由申请人提供):人乳头瘤病毒(HPV)感染是必要的,但不足以发展为宫颈癌。由HPV引起的基因组不稳定性可能使细胞积累额外的遗传异常,这些遗传异常是致癌所必需的,并且与致癌的因果关系有关。HPV E6和E7癌基因在原代人角质形成细胞(PHK)中的表达导致多倍体,其通过纺锤体破坏和DNA损伤而增强。以前,假设E6和E7通过废除有丝分裂纺锤体检查点诱导多倍体,并且E6降解肿瘤抑制因子p53以诱导多倍体。我们最近的研究表明E6和E7对纺锤体检查点没有显著影响。相反,它们废除了有丝分裂后的检查点,以诱导微管破坏后的多倍性。有趣的是,p53降解缺陷的E6突变体也诱导多倍体。此外,我们的研究表明Cdk 4和Cdk 1在E6诱导的多倍体中起重要作用。此外,E7通过再复制诱导多倍体以响应DNA损伤,再复制是一个连续轮的DNA复制过程,而没有居间的有丝分裂。此外,我们发现,DNA复制起始因子Cdt 1,其不受控制的表达诱导在人类癌细胞中的再复制,在E7诱导的再复制过程中被后修饰。我们推测cdk 4和cdk 1的激活在E6诱导的非p53依赖性多倍体中起重要作用,Cdt 1的修饰是E7诱导再复制所必需的,并且E6/E7诱导的多倍体将促进向非整倍体和癌症的进展。该提案的具体目标旨在测试这些可能性。这些研究将揭示HPV诱导基因组不稳定性的机制,并有望为药物开发确定靶点。 公共卫生相关性:人乳头瘤病毒(HPV)感染会诱发疣,并与宫颈癌的发生密切相关。HPV癌基因E6和E7对细胞周期检查点的调节有助于HPV诱导的基因组不稳定性。这些研究将揭示HPV诱导癌症的机制,并有望确定药物开发的靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JASON J CHEN其他文献

JASON J CHEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JASON J CHEN', 18)}}的其他基金

Induction of genomic instability by HPV E6 and E7
HPV E6 和 E7 诱导基因组不稳定
  • 批准号:
    7900009
  • 财政年份:
    2008
  • 资助金额:
    $ 30.63万
  • 项目类别:
Induction of genomic instability by HPV E6 and E7
HPV E6 和 E7 诱导基因组不稳定
  • 批准号:
    8103880
  • 财政年份:
    2008
  • 资助金额:
    $ 30.63万
  • 项目类别:
Induction of genomic instability by HPV E6 and E7
HPV E6 和 E7 诱导基因组不稳定
  • 批准号:
    8305656
  • 财政年份:
    2008
  • 资助金额:
    $ 30.63万
  • 项目类别:
Induction of genomic instability by HPV E6 and E7
HPV E6 和 E7 诱导基因组不稳定
  • 批准号:
    7467125
  • 财政年份:
    2008
  • 资助金额:
    $ 30.63万
  • 项目类别:
Modulation of a novel cell cycle checkpoint by the HPV oncogene E6
HPV 癌基因 E6 对新型细胞周期检查点的调节
  • 批准号:
    7388406
  • 财政年份:
    2008
  • 资助金额:
    $ 30.63万
  • 项目类别:
Modulation of a novel cell cycle checkpoint by the HPV oncogene E6
HPV 癌基因 E6 对新型细胞周期检查点的调节
  • 批准号:
    7554131
  • 财政年份:
    2008
  • 资助金额:
    $ 30.63万
  • 项目类别:
Role of Cdc2 in HPV E6-mediated Apoptosis
Cdc2 在 HPV E6 介导的细胞凋亡中的作用
  • 批准号:
    7081360
  • 财政年份:
    2005
  • 资助金额:
    $ 30.63万
  • 项目类别:
Role of Cdc2 in HPV E6-mediated Apoptosis
Cdc2 在 HPV E6 介导的细胞凋亡中的作用
  • 批准号:
    6967225
  • 财政年份:
    2005
  • 资助金额:
    $ 30.63万
  • 项目类别:
HPV E6 Inhibitors for AIDS-Associated Malignancies
HPV E6 抑制剂治疗艾滋病相关恶性肿瘤
  • 批准号:
    6888305
  • 财政年份:
    2004
  • 资助金额:
    $ 30.63万
  • 项目类别:
HPV E6 Inhibitors for AIDS-Associated Malignancies
HPV E6 抑制剂治疗艾滋病相关恶性肿瘤
  • 批准号:
    6799495
  • 财政年份:
    2004
  • 资助金额:
    $ 30.63万
  • 项目类别:

相似海外基金

Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
  • 批准号:
    10887038
  • 财政年份:
    2023
  • 资助金额:
    $ 30.63万
  • 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
  • 批准号:
    10877239
  • 财政年份:
    2023
  • 资助金额:
    $ 30.63万
  • 项目类别:
The impact of aneuploidy on early human development
非整倍体对人类早期发育的影响
  • 批准号:
    MR/X007979/1
  • 财政年份:
    2023
  • 资助金额:
    $ 30.63万
  • 项目类别:
    Research Grant
Cell competition, aneuploidy, and aging
细胞竞争、非整倍性和衰老
  • 批准号:
    10648670
  • 财政年份:
    2023
  • 资助金额:
    $ 30.63万
  • 项目类别:
Understanding how aneuploidy disrupts quiescence in the model eukaryote Saccharomyces cerevisiae
了解非整倍体如何破坏模型真核生物酿酒酵母的静止状态
  • 批准号:
    10735074
  • 财政年份:
    2023
  • 资助金额:
    $ 30.63万
  • 项目类别:
Preventing Age-Associated Oocyte Aneuploidy: Mechanisms Behind the Drosophila melanogaster Centromere Effect
预防与年龄相关的卵母细胞非整倍性:果蝇着丝粒效应背后的机制
  • 批准号:
    10538074
  • 财政年份:
    2022
  • 资助金额:
    $ 30.63万
  • 项目类别:
Functional evaluation of kinesin gene variants associated with female subfertility and egg aneuploidy.
与女性生育力低下和卵子非整倍性相关的驱动蛋白基因变异的功能评估。
  • 批准号:
    10537275
  • 财政年份:
    2022
  • 资助金额:
    $ 30.63万
  • 项目类别:
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
使用 CRISPR 筛选揭示非整倍体特异性遗传依赖性
  • 批准号:
    10661533
  • 财政年份:
    2022
  • 资助金额:
    $ 30.63万
  • 项目类别:
Comparative Analysis of Aneuploidy and Cellular Fragmentation Dynamics in Mammalian Embryos
哺乳动物胚胎非整倍性和细胞破碎动力学的比较分析
  • 批准号:
    10366610
  • 财政年份:
    2022
  • 资助金额:
    $ 30.63万
  • 项目类别:
FASEB SRC: The Consequences of Aneuploidy: Honoring the Contributions of Angelika Amon
FASEB SRC:非整倍体的后果:纪念 Angelika Amon 的贡献
  • 批准号:
    10467260
  • 财政年份:
    2022
  • 资助金额:
    $ 30.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了